Contenido de sensagent
1.a kind of penicillin (a fungicidal antibiotic with the trade name Fulvicin) produced by molds of the genus Penicillium
1.(MeSH)An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections.
Griseofulvin (n.) [MeSH]
produit qui détruit (fr)[Classe]
antibiotic; antibiotic drug[Classe]
(mushroom; fungus; toadstool)[termes liés]
||This article needs additional citations for verification. (July 2011)|
|Systematic (IUPAC) name|
|(2S,6'R)- 7-chloro- 2',4,6-trimethoxy- 6'-methyl- 3H,4'H-spiro [1-benzofuran- 2,1'-cyclohexene]- 3,4'-dione|
|Pregnancy cat.||B3 (Australia), C (United States)|
|Legal status||POM (UK), ℞-only (U.S.)|
|Bioavailability||Highly variable (25 to 70%)|
|Metabolism||Hepatic demethylation and glucuronidation|
|ATC code||D01 D01|
|Mol. mass||352.766 g/mol|
| (what is this?)
Griseofulvin (marketed under the proprietary name Grifulvin V by Orthoneutrogena Labs, according to FDA orange book) is an antifungal drug that is administered orally. It is used both in animals and in humans, to treat fungal infections of the skin (commonly known as ringworm) and nails. It is produced by culture of some strains of the mold Penicillium griseofulvum, from which it was isolated in 1939.
It binds to keratin in keratin precursor cells and makes them resistant to fungal infections. It is only when hair or skin is replaced by the keratin-griseofulvin complex that the drug reaches its site of action. Griseofulvin will then enter the dermatophyte through energy dependent transport processes and bind to fungal microtubules. This alters the processing for mitosis and also underlying information for deposition of fungal cell walls.
When cancer cells divide (undergo mitosis), they use an unusual mechanism to ensure the correct genetic material is present within each of the resulting tumor cells. Laboratory experiments at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) show that griseofulvin causes cancer cells to fail to divide the chromosomes correctly, which eventually leads to tumor cell death. Griseofulvin does not interfere with cell division in healthy cells. The observed effect is not strong, but is significant. Griseofulvin may be combined with other treatments to improve its effectiveness and may lead to the development of more effective future drug treatments with very low toxic side effects.
Known side effects of griseofulvin include: